Parkinson’s Disease (PD) Market in United States, United Kingdom– Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030)

1. Executive Summary: Parkinson’s Disease (PD)
   • Global Market Outlook: Parkinson’s Disease (PD)
2. Competitive Intelligence Analysis: Parkinson’s Disease (PD)
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Parkinson’s Disease (PD)
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Disease Overview: Parkinson’s Disease (PD)
   • Disease Etiology
   • Pathophysiology
   • Risk Factors
   • Treatment Algorithm
7. Parkinson’s Disease (PD): Key Marketed Products Profile – Major Approved Products
   • Product Profile
   • Regulatory Milestones
   • Safety and Efficacy
   • Clinical Development
8. Parkinson’s Disease (PD): Promising Pipeline Candidates – Major Products in Late Stage of Development
   • Product Description
   • Safety and Efficacy
   • Research and Development
9. Regulatory Landscape
10. Parkinson’s Disease (PD): Eight Major Market (8MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
11. S. Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
12. K. Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
13. Germany Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
14. France Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
15. Italy Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
16. Spain Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
17. Japan Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
18. China Parkinson’s Disease (PD) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
19. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

20. Assumptions and Acronyms Used
21. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
22. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, and China
23. Copyrights and Disclaimer

Parkinson’s Disease Market – Report Overview

Pacific Business Consulting’s “Parkinson’s Disease (PD) Market in 8MM – Market Insights, Unmet Needs, Market Assessment and Forecast (2023-2030) ” report offers a comprehensive understanding of Parkinson’s Disease, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Eight Major Markets (8MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and China.

The Parkinson’s Disease market size within the Eight Major Markets (8MM) was valued at US$xx billion in 2022 and is projected to achieve a Compound Annual Growth Rate (CAGR) of more than xx% during the period from 2023 to 2030. The United States stands as the primary contributor to this revenue, primarily attributed to the significantly higher drug costs compared to other countries in the 8MM.

The diagnosed prevalent cases of Parkinson’s Disease (PD) are expected to rise, primarily driven by the increasing aging population across the 8MM over the next decade. Drugs approved for niche populations are anticipated to receive label extensions into broader patient populations, allowing for the expansion of their target patient pool. Notable pipeline products, including Annovis Bio’s Buntanetap, BioVie’s NE-3107, Neuraly’s NLY01, and Roche/Prothena’s prasinezumab, are under investigation for their disease-modifying or neuroprotective properties.

However, several leading drugs in the market will face patent expiry, leading to a decline in branded drug sales as the market becomes inundated with more affordable generic versions. Additionally, the high utilization of inexpensive generic products is expected to persist throughout the forecast period. The absence of validated predictive biomarkers for PD progression has posed challenges in developing disease-modifying therapies and neuroprotective agents.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Parkinson’s Disease market. It also delves into the analysis of present and prospective market competition within the global Parkinson’s Disease market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Parkinson’s Disease market across the 8MM (Eight Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 8MM Parkinson’s Disease market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Please note that detailed pipeline analysis can be provided along with the standard scope to assist you in developing and designing your in-licensing and out-licensing strategies. This includes a review of pipeline products and technologies, along with identifying companies with the most robust pipeline.